Predictive biomarkers for the recurrence of non‑small cell lung cancer (NSCLC) in patients
who have received curative resection are important for cancer treatment. The functional …

Objectives: The aim of this study was to clarify the usefulness of plasma exosomal microRNA-
451a (miR-451a) as a novel biomarker for the early prediction of recurrence and prognosis …

Abstract Background Deregulated circulating microRNAs (miRNAs) are potential biomarkers
for the early detection and prognosis prediction of non–small‐cell lung cancer (NSCLC). The …

Patients with non‐small‐cell lung cancer (NSCLC) frequently develop radioresistance,
resulting in poor response to radiation and unfavourable prognosis. Early detection of …

Exosomal miRNAs are proposed as excellent candidate biomarkers for clinical applications.
However, little is known about their potential roles as prognostic biomarkers in lung cancer …

Background Delayed diagnosis is the main obstacle to improve prognosis of non-small cell
lung cancer (NSCLC). Novel biomarkers for the diagnosis of NSCLC are urgently needed …

Prognosis of lung cancer still remains grim largely due to recurrence and aggressive
metastasis of the disease. In this study, we examined the potential of exosomal miRNAs as …

Circulating exosomal microRNAs (ExmiRNAs) provide an ideal non-invasive method for
cancer diagnosis. In this study, we evaluated two circulating ExmiRNAs in NSCLC patients …

Purpose To date, there is no screening test for lung cancer shown to affect overall mortality.
MicroRNAs (miRNAs) are a class of small noncoding RNA genes found to be abnormally …

Background. Evidence has suggested the functional role of exosomal miRNAs in cancer
diagnosis. This study aimed to determine whether the serum exosomal biomarkers can …